An Open-label Study to Identify Molecular Markers of Steroid Resistance in Nasal Polyposis Before and Following Treatment With Mometasone Furoate (MFNS) 2 Sprays/Nostril (100 Mcg/Nostril) Twice Daily for 4 Weeks.
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Mometasone (Primary)
- Indications Nasal polyps; Rhinosinusitis
- Focus Pharmacodynamics; Pharmacogenomic
- 21 Apr 2015 New trial record